JA-24-Edg-632_TPOXX_Redacted.pdf

This document is a Justification and Approval (J&A) for a sole source contract to procure additional doses of oral TPOXX and IV TPOXX treatment courses to maintain the national stockpile of smallpox therapeutics. The purpose is to award a contract to Siga Technologies Inc. for an unknown amount on 2024-08-02. Both TPOXX treatment courses have been approved by the FDA. The contract will be awarded by the Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground (ACC Aberdeen Proving Ground), a defense agency.